Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution

By La Verde Nicla  

Supportive Care in Cancer, Vol. 16, Iss. 11, 2008-11 ,pp. : 1311-1315

Springer Publishing Company

Access to resources Recommend Favorite

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents

By Aragon-Ching Jeanny   Ning Yang-Min   Chen Clara   Latham Lea   Guadagnini Jean-Pierre   Gulley James   Arlen Philip   Wright John   Parnes Howard   Figg William   Dahut William  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 221-226

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

By Guarneri Valentina  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: A retrospective analysis

By Ortega Cinzia   Montemurro Filippo   Faggiuolo Roberto   Vormola Roberto   Nanni Daniela   Goia Franco   Gilardino Marco Ottavio   Aglietta Massimo  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 664-668

Informa Healthcare

Access to resources Recommend Favorite

Jaw Osteonecrosis in Patients Treated with Bisphosphonates: An Ultrastructural Study

By Perrotta I.   Cristofaro M. G.   Amantea M.   Russo E.   De Fazio S.   Zuccalà V.   Conforti F.   Amorosi A.   Donato G.   Tripepi S.   Giudice M.  

Ultrastructural Pathology, Vol. 34, Iss. 4, 2010-08 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite